Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-22-003583
Filing Date
2022-04-29
Accepted
2022-04-29 20:58:57
Documents
1
Period of Report
2022-04-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4180
  Complete submission text file 0001562180-22-003583.txt   5573
Mailing Address C/O CORNERSTONE THERAPEUTICS INC. 1255 CRESCENT GREEN DRIVE, SUITE 250 CARY NC 27518
Business Address
Heffernan Michael Thomas (Reporting) CIK: 0001448914 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38080 | Film No.: 22878758

Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Issuer) CIK: 0001689813 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations